Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Frontiers of Radiation Therapy and Oncology|December 4, 2009
Stereotactic body radiation therapy for early non-small cell lung cancerFrank Zimmermann, Jörn Wulf, Ingmar Lax, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2006
Dose distributions in SBRT of lung tumors: Comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motionsIngmar Lax, Vanessa Panettieri, Berit Wennberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2011
Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapyHeike Peulen, Kristin Karlsson, Karin Lindberg, et al.
Acta Oncologica (Stockholm, Sweden)|January 15, 2021
Extending hypofractionated stereotactic body radiotherapy to tumours larger than 70cc - effects and side effectsVitali Grozman, Eva Onjukka, Peter Wersäll, et al.
Acta Oncologica (Stockholm, Sweden)|August 18, 2025
Validated prediction of xerostomia in a real-world population: a step toward model-guided radiotherapyEmmy Dalqvist, Tiziana Rancati, Anna Embring, et al.
Radiation Oncology (London, England)|June 10, 2020
Overlapping volumes in re-irradiation for head and neck cancer - an important factor for patient selectionAnna Embring, Eva Onjukka, Claes Mercke, et al.
Medical Oncology (Northwood, London, England)|July 21, 2012
A retrospective study of SBRT of metastases in patients with primary sarcomaChristina Linder Stragliotto, Kristin Karlsson, Ingmar Lax, et al.
Neurosurgery|July 1, 2005
Long-term results after fractionated radiation therapy for large brain arteriovenous malformationsBengt Karlsson, Melker Lindqvist, Henric Blomgren, et al.
Annals of Surgery|November 17, 2016
Risk of Acute Testicular Failure After Preoperative Radiotherapy for Rectal Cancer: A Prospective Cohort StudyChristian Buchli, Anna Martling, Massoud Al Abani, et al.
Cancers|July 2, 2021
Re-Irradiation for Head and Neck Cancer: Cumulative Dose to Organs at Risk and Late Side EffectsAnna Embring, Eva Onjukka, Claes Mercke, et al.
Pageof 5